Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.53 |
| ▸ | SLC29A1 | Q99808 | 4/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Riboprine SCHEMBL28121660 | 0.89 | SLC29A1 (0.46) | TP53LMNAALOX15TSHRHTT | |
| Riboprine SCHEMBL28250734 | 0.82 | SLC29A1 (0.39) | TP53LMNAALOX15TSHRHTT | |
| Riboprine SCHEMBL28124720 | 0.81 | SLC29A1 (0.39) | TP53LMNAALOX15TSHRHTT | |
| Riboprine SCHEMBL4600 | 0.80 | TP53 (0.79) | TP53LMNAALOX15TSHRHTT | |
| Riboprine SCHEMBL1763190 | 0.80 | TP53 (0.79) | TP53LMNAALOX15TSHRHTT | |
| Riboprine SCHEMBL29552839 | 0.80 | TP53 (0.79) | TP53LMNAALOX15TSHRHTT | |
| Riboprine SCHEMBL18870819 | 0.80 | TP53 (0.79) | TP53LMNAALOX15TSHRHTT | |
| Riboprine SCHEMBL4599 | 0.80 | TP53 (0.79) | TP53LMNAALOX15TSHRHTT | |
| Riboprine SCHEMBL4815729 | 0.80 | TP53 (0.79) | TP53LMNAALOX15TSHRHTT | |
| Riboprine SCHEMBL18503566 | 0.80 | TP53 (0.79) | TP53LMNAALOX15TSHRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003097835-A2 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER | MOLECULAR ENGINES LABORATORIES (FR) | 2003-11-27 | — | — | WO | disclosed |